Dexmedetomidine ameliorates liver injury and maintains liver function in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study with propensity score matching

Dexmedetomidine ameliorates liver injury and maintains liver function in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study with propensity score matching

BackgroundAlthough dexmedetomidine (DEX) is widely used during the perioperative period in patients with hepatocellular carcinoma (HCC), its clinical effects on liver function and postoperative inflammation are unclear. This study aimed to explore effects of DEX on postoperative liver function and i...

Full description

Bibliographic Details
Main Authors: Xiaoqiang Wang, Yi-ran Li, Yumiao Shi, Xiaoying Li, Jiamei Luo, Yiqi Zhang, Bo Qi, Feixiang Wu, Yuming Sun, Zhiying Pan, Jie Tian
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
liver injury
inflammation
perioperative organ damage
dexmedetomidine
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1108559/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1108559/full

Similar Items